Stocks
Funds
Screener
Sectors
Watchlists
INFU

INFU - InfuSystem Holdings Inc Stock Price, Fair Value and News

$8.37+0.41 (+5.15%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

INFU Price Action

Last 7 days

-6.1%


Last 30 days

-7.2%


Last 90 days

29.6%


Trailing 12 Months

-21.8%

INFU RSI Chart

INFU Valuation

Market Cap

178.0M

Price/Earnings (Trailing)

119.93

Price/Sales (Trailing)

1.34

EV/EBITDA

13.93

Price/Free Cashflow

10.98

INFU Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

INFU Fundamentals

INFU Revenue

Revenue (TTM)

132.8M

Rev. Growth (Yr)

10.69%

Rev. Growth (Qtr)

4.81%

INFU Earnings

Earnings (TTM)

1.5M

Earnings Growth (Yr)

162.26%

Earnings Growth (Qtr)

152.02%

INFU Profitability

EBT Margin

2.65%

Return on Equity

2.67%

Return on Assets

1.41%

Free Cashflow Yield

9.11%

INFU Investor Care

Shares Dilution (1Y)

0.38%

Diluted EPS (TTM)

0.07

INFU Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024127.4M129.4M132.8M0
2023113.5M118.2M122.8M125.8M
2022104.7M106.9M107.6M109.9M
2021100.3M99.1M100.6M102.4M
202084.5M90.8M94.4M97.4M
201968.8M72.2M77.0M81.1M
201869.9M69.4M68.5M67.1M
201769.9M68.7M69.0M71.1M
201672.3M73.5M72.4M70.5M
201565.8M66.4M68.1M70.5M
201464.8M66.5M67.4M66.5M
201359.2M59.8M61.3M62.3M
201256.0M57.0M56.6M58.8M
201149.3M51.9M53.7M54.6M
2010041.7M44.5M47.2M
200900039.0M
INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
 CEO
 WEBSITEinfusystem.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES420

InfuSystem Holdings Inc Frequently Asked Questions


What is the ticker symbol for InfuSystem Holdings Inc? What does INFU stand for in stocks?

INFU is the stock ticker symbol of InfuSystem Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of InfuSystem Holdings Inc (INFU)?

As of Fri Dec 20 2024, market cap of InfuSystem Holdings Inc is 177.98 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INFU stock?

You can check INFU's fair value in chart for subscribers.

Is InfuSystem Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether INFU is over valued or under valued. Whether InfuSystem Holdings Inc is cheap or expensive depends on the assumptions which impact InfuSystem Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INFU.

What is InfuSystem Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, INFU's PE ratio (Price to Earnings) is 119.93 and Price to Sales (PS) ratio is 1.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INFU PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on InfuSystem Holdings Inc's stock?

In the past 10 years, InfuSystem Holdings Inc has provided 0.113 (multiply by 100 for percentage) rate of return.